| Opportunity ID: |
333324 |
| Opportunity Number: |
NOT-AA-21-023 |
| Opportunity Title: |
Notice of Intent to Publish a Funding Opportunity Announcement for Collaborative Initiative on Fetal Alcohol Spectrum Disorders (CIFASD), Data Coordination Core (U24 Clinical Trial Not Allowed) |
| Opportunity Category: |
Discretionary |
| Opportunity Category Explanation: |
|
| Funding Instrument Type: |
Cooperative Agreement |
| Category of Funding Activity: |
Health |
| Category Explanation: |
|
| CFDA Number(s): |
93.273 |
| Eligible Applicants: |
State governments
County governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: |
|
| Agency Code: |
HHS-NIH11 |
| Agency Name: |
Department of Health and Human Services
National Institutes of Health |
| Posted Date: |
May 04, 2021 |
| Last Updated Date: |
May 04, 2021 |
| Estimated Synopsis Post Date: |
May 15, 2021 |
| Fiscal Year: |
2022 |
| Award Ceiling: |
|
| Award Floor: |
|
| Estimated Total Program Funding: |
$4,600,000 |
| Expected Number of Awards: |
1 |
| Description: |
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) intends to publish Funding Opportunity Announcements (FOAs) to solicit applications from current awardees and new applicants to continue the previously funded “Collaborative Initiative on Fetal Alcohol Spectrum Disorders” (CIFASD). Responsive applications are expected 1) to address urgent and important unmet needs in the fetal alcohol spectrum disorders (FASD) field in the areas of diagnosis/case identification, intervention, basic and mechanistic studies, and prevention; 2) to use integrated and multidisciplinary research approaches and leverage multiple cohorts of individuals with FASD. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. The FOA is expected to be published in Spring 2021 with an expected application due date in Summer 2021. This FOA will utilize the U24 Clinical Trial Not Allowed activity code. Details of the planned FOA are provided below. |
| Version: |
1 |
